The in vitro immunosuppressive effects of moclobemide in healthy volunteers

Journal of Affective Disorders

Volumn 58, Issue 1, 2000, Pages 69-74

  Lin, Aihua ^a,b   Song, Cai ^a,c   Kenis, Günter ^c,d   Bosmans, Eugene ^c   De Jongh, Raf ^d   Scharpé, Simon ^b   Maes, Michael ^a,e,f  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c CARLETON UNIVERSITY   (Canada)

^d Department of Anesthesiology ^*  (Belgium)

^e VANDERBILT UNIVERSITY   (United States)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cytokine; Depression; IL 10; IL 8; Moclobemide; TNF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VOLUNTEER;

ADULT; ANTIDEPRESSIVE AGENTS; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MALE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; REFERENCE VALUES;

EID: 0034177484     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00076-2     Document Type: Article

References (32)

1. Amrein R., Hetzel W., Stabl M., Schmid-Burgk W. RIMA: a new concept in the treatment of depression with moclobemide. Int. Clin. Psychopharmacol. 7:1993;123-132.
2. Berk M., Wadee A.A., Kuschke R.H., O'Neill-Kerr A. Acute phase proteins in major depression. J. Psychosom. Res. 43:1997;529-534.
3. Bonaccorso S., Lin A., Verkerk R., VanHunsel F., Libbrecht I., Scharpé S., DeClerck L., Biondi M., Janca A., Maes M. Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers. J. Affect. Disord. 48:1998;75-82.
4. Calabrese J.R., Skwerer R.G., Barna B., Gulledge A.D., Valenzuela R., Butkus A., Subichin S., Krupp N.E. Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res. 17:1986;41-47.
5. Cavaillon J.-M. Les Cytokines. 1996;Masson, Paris.
6. DeGroote D., Zangerle P.F., Gevaert Y., Fassotte M.F., Beguin Y., Noizat-Pirenne F., Pirenne J., Gathy R., Lopez M., Dehart I., Igot D., Baudrihaye M., Delacroix D., Franchimont P. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine. 4:1992;239-248.
7. Duch D.S., Woolf J.H., Nichol C.A., Davidson J.R., Garbutt J.C. Urinary excretion of biopterin and neopterin in psychiatric disorders. Psychiatry Res. 11:1984;83-89.
8. Dunbar P.R., Hill J., Neale T.J., Mellsop G.W. Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol. Med. 22:1992;1051-1057.
9. Elsasser-Beile U., vonKleist S., Gallati H. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods. 139:1991;191-195.
10. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatr. Clin. Neurosci. 247:1997;228-233.
11. Gieschke R., Schmid-Burgk W., Amrein R. Interaction of moclobemide, a new reversible monoamine oxidase inhibitor, with oral tyramine. J. Neural. Transm. 26:1988;97-104.
12. Guentert T.W., Mayersohn M. Clinical-pharmacokinetic profile of moclobemide and its comparison with other MAO-inhibitors. Rev. Contemp. Pharmacother. 5:1994;19-34.
13. Joyce P.R., Hawes C.R., Mulder R.T., Sellman J.D., Wilson D.A., Boswell D.R. Elevated levels of acute phase proteins in major depression. Biol. Psychiatry. 32:1992;1035-1041.
14. Kubera, M., Holan, V., Basta-Kaim, A., Roman, A., Borycz, J., Shani, J., 1998. Effect of desipramine on immunological parameters in mice, and their reversal by stress. J. Immunopharmacol. (in press).
15. Larsen C.G., Anderson A.O., Oppenheim J.J., Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor. Immunology. 68:1989;31-36.
16. Linnoila M., Whorton R., Rubinow D.R., Cowdry R.W., Niana P.T., Waters R.N. CSF prostaglandin levels in depressed and schizophrenic patients. Arch. Gen. Psychiatry. 40:1983;405-406.
17. Maes M., Scharpé S., Van Grootel L., Uyttenbroeke W., Cooreman W., Cosyns P., Suy E. Higher α1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J. Affect. Disord. 24:1992;183-192.
18. Maes M., Scharpé S., Meltzer H.Y., Okayli G., Bosmans E., D'Hondt P., VandenBossche B., Cosyns P. Increased neopterin and interferon g secretion and lower availability of L-tryptophan in major depression: further evidence for activation of cell-mediated immunity. Psychiatr. Res. 54:1994;143-160.
19. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6 receptor, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34:1995;301-309.
20. Maes M., Vandoolaeghe E., Ranjan R., Bosmans E., Bergmans R., Desnyder R. Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J. Affect. Disord. 36:1995;29-36.
21. Maes M., Song C., Lin A., Gabriels L., De Jongh R., Van Gastel A., Kenis G., Bosmans E., De Meester I., Benoyt I., Neels H., Demedts P., Janca A., Scharpé S., Smith R.S. The effects of psychological stress on humans: increased production of proinflammatory cytokines and a Th-1-like response in stress-induced anxiety. Cytokine. 10:1998;313-318.
22. Maes M., Song C., Lin A., De Jongh R., Kenis G., Bosmans E., De Meester I., Neels H., Scharpé S. Immune and clinical correlates of psychological stress-induced production of interferon-γ and IL-10 in humans. Plotnikoff N.P., Faith R.E., Murgo A.J., Good R.A., Cytokines, Stress and Immunity. 1998;39-50 CRC Press, Boca-Raton, FL.
23. Maes M., Song C., Lin A., Bonaccorso S., Scharpe S., Kenis G., Bosmans E. Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 20:1999;370-379.
24. Schmid-Burgk W., Gieschke R., Allen S.R., Amrein R. Moclobemide, a new reversible monoamine oxidase inhibitor, and tyramine interaction studies. Curr. Ther. Res. 43:(5):1988.
25. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H. Cytokine production and serum proteins in depression. Scand. J. Immunol. 41:1995;534-538.
26. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H. Increased CD56+ natural killer cells and related cytokines in major depression. Clin. Immunol. Immunopathol. 78:1996;83-85.
27. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., Wiktorowiz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. NY Acad. Sci. 762:1995;474-476.
28. Sluzewska A., Rybakowski J.K., Bosmans E., Sobieska M., Bergmans R., Maes M., Wiktorowicz K. Indicators of immune activation in major depression. Psychiatr. Res. 64:1996;161-167.
29. Sluzewska A., Rybakowski J.K., Sobieska M., Wiktorowicz K. Concentrations and microheterogeneity glycoforms of alpha-1-acid glycoprotein in major depression. J. Affect. Disord. 39:1996;149-155.
30. Song C., Dinan T., Leonard B.E. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J. Affect. Disord. 30:1994;283-288.
31. Xia Z., DePierre J.W., Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1β and TNFα release in human blood monocytes and IL-2 and interferon-γ in T cells. Immunopharmacology. 34:1996;27-37.
32. Zangerle P.F., DeGroote D., Lopez M., Meuleman R.J., Vrindts Y., Fauchet F., Dehart I., Jadoul M., Radoux D., Franchimont P. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine. 4:1992;568-575.